The Food and Drug Administration (FDA) inspected Creative Foam Corporation in Mooresville on Feb. 4 concerning drug quality assurance, according to data posted on the FDA’s website.
The resulting report recommended that Creative Foam Corporation implement voluntary actions to address the organization’s management processes.
The FDA regularly examines facilities nationwide to verify compliance of their environments and products with agency regulations designed to enhance public health. The findings from these inspections are released to the public.
The FDA states on its website that it is a government body mainly responsible for overseeing the safety and quality of human and animal drugs, biological products, medical devices and tobacco products throughout the supply chain.
Information in this article was obtained from the U.S. Food and Drug Administration. The source data can be found here.
